Esperion Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 1.64658325
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

1.41 -0.06 (-4.08%)

64.21% Fall from 52W High

4.4M

XNAS Volume

High vol.+gain this week

XNAS 30 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Esperion Therapeutics Inc. is on 05 Aug 2025 for the purpose of Esperion Therapeutics Inc Second Quarter Earnings Results for 2025 See details